Skip to main content
APPLY

Position 04 · Regulation and evidence

STATUS, EVIDENCE AND MARKETING ARE THREE DIFFERENT THINGS.

The position

Our position: in this category, regulatory status, the quality of human evidence and the language used to sell a compound are routinely blurred together. Each is a separate question, and answering one does not answer the others. Ascendant Health does not recommend, source or manage compounds, and treats confident marketing as the weakest of the three signals.

The evidence

Approved, not approved, or approved for something else

The client material distinguishes three situations that are frequently presented as one: a compound approved for a specific medical use, a compound approved for a different indication than the one being marketed, and a compound with no approval for human use in this setting. Which of the three applies is a question of record, and it is answerable — a clinician or provider should be able to state it plainly.

  • Regulator guidance on compounding categories and unapproved substancesReference listed without a direct link.

Human evidence versus animal and laboratory evidence

Mechanistic and animal work describes what might happen. Human studies describe what has been observed in people, in a defined population, under defined conditions. Interest in a mechanism is not a clinical result, and the two are often quoted interchangeably.

Marketing language versus regulatory status

Marketing borrows the vocabulary of research — terms like clinical, pharmaceutical-grade, or research-backed — without carrying its substance, and rarely states regulatory status plainly. Nothing on this site describes a compounded product as approved; where the exact status is unverified, we say so rather than characterise it.

The concession

Research in this area may be genuinely promising, and some compounds do have approved medical uses. Promising research is not the same as proven clinical benefit — but treating the whole category as worthless is its own error.

What to do instead

  • Establish the regulatory status for this specific use before anything else.
  • Ask whether the evidence being cited is human, animal or laboratory work.
  • Separate what a vendor claims from what a clinician can confirm.
  • Treat unanswered questions as unanswered rather than reassuring.

Questions to ask before you agree to anything

  1. 01What is the regulatory status of this compound for this use?
  2. 02What human evidence exists, and what did it measure?
  3. 03Is the evidence being cited from people, animals or a laboratory?
  4. 04What is known about the risks — and what is simply unknown?
  5. 05Why is this being suggested instead of an approved treatment?

Sources

Primary references for this position are being verified. Nothing is cited here until a source has been checked.

Related writing

The supporting writing for this position is in preparation.

Browse all writing

This page is an editorial position. It is not medical advice, a diagnosis or treatment guidance, and it does not recommend for or against any medication. Decisions about treatment belong with a qualified physician who knows your history.

Ascendant Health is a coaching service. It does not practise medicine or prescribe.